borderline significanceP = 0.052
While significant risk reduction by 12% ( P = 0.029) in the incidence of any diabetes-related end point in the intensive treatment group was observed, nonfatal and fatal MI incidence was reduced by 16% with a borderline significance ( P = 0.052) ( 8 ).